SlideShare a Scribd company logo
http://www.free-powerpoint-templates-design.com
Skin sensitisation (OECD. 406)
Prepared by:
Momin Asran Zunnurain Khalid Ak
Guided by: Dr. Aman B. Upganalwar
M. PHARM FIRST YEAR
(department of pharmacology)
SNJB’s SSDJ College of Pharmacy, Chandwad
Skin Sensitisation(OECD GUIDELINE NO. 406)
INTRODUCTION:
• Skin sensitisation is defined as allergic response to a
substance after skin contact.
• Sensitisation is a immune system respose to chemical.
• Symptoms of sensitisation are often seen in skin.
• There are two type of animal use
1. Guinea Pig
2. Mouse
Guinea Pig
Two type of test:
1. Freuds complete adjuvants
(Guinea Pig Maximisation test)
2. Non adjuvants test
(Buehler test)
In the original guideline 406,
Four adjuvants test and three non adjuvants test
Mouse
Immune system of the mouse has been investigated more
extensive than that of the Guinea pig
Advantages – short duration and minimal animal treatment
Example:
1. Mouse ear swelling test
2. Local lymph node assay
Guinea pig maximisation test
• The guinea pig maximisation test (GPMT) is an in
vivo test to screen for substance that cause human
skin sensitisation (i.e. Allergens)
• It was first proposed by B. Magnussom and albert
kligman in 1669 and described in their 1970 book
contact dermatitis in the guinea pi
General principle of sensitisation test
• The test animal are initially exposed to the test substance by
intra dermal injection and epidermal application
• Following a rest period of 10 to 14 days during which an
immune response developed, the animal are exposed to a
challange dose
• The degree of skin reaction to the challange exposure in test
animal is compared with control group animals
Element common to sensitisation test in
Guinea Pig
01
Guinea pig
Animal
03 250-500g
Body weight
05 Temperature=20℃
HR=30-70%
12hrs light & 12hrs dark
Housing
02 Male
Female (non pregnant)
Sex
04 At least 5 days prior to
the test
Acclimatization
06
Feeding
Method
NUMBER OF ANIMAL
A minimum of 10 animal are used in the treatment group and at least 5
animals in the control group are used
(20 test and 10 control)
INDUCTION: INTRADERMAL INJECTION
Day 0 – treated group
1. Three pair of intradermal injection are given in the shoulder region
1/1 mixture of FCA/water or saline
2. Test substance in an appropriate vehicle at the selected concentration
3. Test substance in a 1/1mixture of FCA/water or saline
Day 0 – control group
Control groupe also receive three intradermal injection, but only vehicle
is used
Day 5-7: Treated and control group
24 hrs before topical application,
The test area after close clipping or saving painted with 0.5 ml of 10%
sod lauryl sulphate In Vaseline, in order to creat a local irritation
Day 6-8 : treated group
Shaving
Test substance applied to test area for 48 hrs
Day 6-8 : control group
Shaving
Only vehicle are applied in similar manner for 48 hrs
Day 20-22 : treated and control group
A patches loaded with test substance is applied to flank of animal
And
A patches loaded with vehicle is applied to other side of flank
For 24 hrs
Observation : treated and control group
Remove patch after 24 hrs
Clean area after 21 hrs of patch removal
Observe after 3 hrs (appropriate 48 hrs after challange)
Approximately 24 hrs after this observation A second observation 72 hrs
Scale for the evaluation of challenge patch
test reaction
3=Intense
erythema and
swelling
2=Moderate erythema
1=Discrete or patchy
erythema
0=No visible change
Rechallenge
• If it is necessary to clarify the results obtaine
d in the first challenge
• A second challenge
1. With a new control group / original group
2. Should be considered approximately one
week after the first one
3. Rechallenge may also be performed on the
original control group
Clinical observation
All skin reactions and any unusual findings,
including systematic reactions, result from
induction and challenge procedures should
be observed and recorded
Buehler test
• The bhehler test is an in vivo test to screen for
substance that cause human skin sensitisation
(i.e. Allergens)
• It was first proposed by Edwin Buehler in 1965
and further explained in 1980.
Number of animals :
• A minimum of 20 animals is used in the treatment group and at least 10
animals in the control group
Dose levels :
• The concentration for each induction exposure should be the highest to
cause (mild irritation)
• The concentration used for the challenge exposure should be the highe
st (non-irritating dose)
• The appropriate concentration can be determined from pilot study Using
two or three animals
Methode
Induction : Topical application
Day 0 – treated group
One flank is cleared of hair (closely clipped)
The test patch system should be fully loaded with test substance in a suitable
vehicle is applied to the test area and held in contact with the skin for 6 hours.
Day 0 - control group
One flank is cleared of hair (closely clipped)
The only vehicle applied on a similar manner of test application.
Days 6 – 8 and 13 – 15 treated and control group
The some application as on day 0 is carried out on the same test area of
same flank on day 6-8 and again on day 13-15.
Challenge
Day 27 – 29 treated and control groups
• The untreated flank of treated and control animals is cleared of hair.
• An occlusive patch or chamber containing the appropriate amount of
test substance is applied, at the maximum non irritant concentration, to
the posterior untreated flank of treated and control animals
• The patches or chambers are held in contact by a suitable dressing for
6 hours.
Observation – treated and control groups :
• Challenge area is cleared of hair 21 hours after removing the patch
• 3 hours later the skin reaction are observed and recorded
• Approximately 24 hours after the skin reaction observed and recorded
Rechallenge:
To clarify the results obtained in the first challenge
Clinical observations
• All skin reactions
• Any usual findings
1. Systemic reactions
• To clarify doubtful reactions
1. Histopathological examination
2. Measurement of skin fold thickness
Reference
OECD (1992) , Skin sensitisation. OECD Guideline for
the testing of Chemicals No. 406, Paris, France.
Thank you
Insert the title of your subtitle Here

More Related Content

What's hot

Acute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelinesAcute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelines
madhvi Chaubey
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Ch. Bhargava krishna
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
Anurag Chourasia
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
Himanshu Yadav
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
HimikaRathi
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
pradnya Jagtap
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
Dr Ajay Mandal
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
Khadga Raj
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
jeshicabulsara
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
ragini Dani
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
ARSHIKHANAM4
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
JanhaviBurade
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
ashharnomani
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
Shikha Choudhary
 
industrial prespectives of IND
industrial prespectives of INDindustrial prespectives of IND
industrial prespectives of IND
Ravi Kumar katukuri
 
OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)
Naveen K L
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
AnimatedWorld
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
pharmacistnitish
 
Kk Test item characterization
Kk Test item characterizationKk Test item characterization
Kk Test item characterization
Keshari Sriwastawa
 

What's hot (20)

Acute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelinesAcute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelines
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
 
industrial prespectives of IND
industrial prespectives of INDindustrial prespectives of IND
industrial prespectives of IND
 
OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 
Kk Test item characterization
Kk Test item characterizationKk Test item characterization
Kk Test item characterization
 

Similar to skin sensitisation test

DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINESDERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
MO.SHAHANAWAZ
 
Skin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptxSkin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptx
NikitaBankoti2
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
Dr Ajay Mandal
 
dermal toxicity.pptx
dermal toxicity.pptxdermal toxicity.pptx
dermal toxicity.pptx
VaishnaviPatel76
 
dermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptxdermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptx
yashvikhankar1
 
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptxDermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Ashish Gadage
 
acute dermal irritation .pptx
acute dermal irritation .pptxacute dermal irritation .pptx
acute dermal irritation .pptx
jatinsaini78
 
Acute Eye Irritation\Corrosion toxicology studies
Acute Eye Irritation\Corrosion  toxicology studiesAcute Eye Irritation\Corrosion  toxicology studies
Acute Eye Irritation\Corrosion toxicology studies
Himanshu Yadav
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
MADHAV JAJNURE
 
BioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptxBioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptx
HafezHawas1
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
Priya818982
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
PurushothamKN1
 
OECG Dermatotoxicity testing
OECG Dermatotoxicity testingOECG Dermatotoxicity testing
OECG Dermatotoxicity testing
Sandip Chaudhari
 
Testing of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelinesTesting of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelines
GAUTAM KHUNE
 
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptxAcute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Dublinmatcher
 
Skin Sensitization Testing
Skin Sensitization TestingSkin Sensitization Testing
Skin Sensitization Testing
pp_shivgunde
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
Dr Ajay Mandal
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
Sravani Ganti
 
Expt. 10 Determination of acute skin irritation corrosion of a test substance
Expt. 10 Determination of acute skin irritation  corrosion of a test substanceExpt. 10 Determination of acute skin irritation  corrosion of a test substance
Expt. 10 Determination of acute skin irritation corrosion of a test substance
VISHALJADHAV100
 
Evaluation of parenterals
Evaluation of parenteralsEvaluation of parenterals
Evaluation of parenterals
GeetaKhillari
 

Similar to skin sensitisation test (20)

DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINESDERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
 
Skin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptxSkin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptx
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
 
dermal toxicity.pptx
dermal toxicity.pptxdermal toxicity.pptx
dermal toxicity.pptx
 
dermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptxdermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptx
 
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptxDermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
 
acute dermal irritation .pptx
acute dermal irritation .pptxacute dermal irritation .pptx
acute dermal irritation .pptx
 
Acute Eye Irritation\Corrosion toxicology studies
Acute Eye Irritation\Corrosion  toxicology studiesAcute Eye Irritation\Corrosion  toxicology studies
Acute Eye Irritation\Corrosion toxicology studies
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
 
BioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptxBioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptx
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
 
OECG Dermatotoxicity testing
OECG Dermatotoxicity testingOECG Dermatotoxicity testing
OECG Dermatotoxicity testing
 
Testing of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelinesTesting of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelines
 
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptxAcute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
 
Skin Sensitization Testing
Skin Sensitization TestingSkin Sensitization Testing
Skin Sensitization Testing
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Expt. 10 Determination of acute skin irritation corrosion of a test substance
Expt. 10 Determination of acute skin irritation  corrosion of a test substanceExpt. 10 Determination of acute skin irritation  corrosion of a test substance
Expt. 10 Determination of acute skin irritation corrosion of a test substance
 
Evaluation of parenterals
Evaluation of parenteralsEvaluation of parenterals
Evaluation of parenterals
 

Recently uploaded

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 

Recently uploaded (20)

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 

skin sensitisation test

  • 1. http://www.free-powerpoint-templates-design.com Skin sensitisation (OECD. 406) Prepared by: Momin Asran Zunnurain Khalid Ak Guided by: Dr. Aman B. Upganalwar M. PHARM FIRST YEAR (department of pharmacology) SNJB’s SSDJ College of Pharmacy, Chandwad
  • 2. Skin Sensitisation(OECD GUIDELINE NO. 406) INTRODUCTION: • Skin sensitisation is defined as allergic response to a substance after skin contact. • Sensitisation is a immune system respose to chemical. • Symptoms of sensitisation are often seen in skin. • There are two type of animal use 1. Guinea Pig 2. Mouse
  • 3. Guinea Pig Two type of test: 1. Freuds complete adjuvants (Guinea Pig Maximisation test) 2. Non adjuvants test (Buehler test) In the original guideline 406, Four adjuvants test and three non adjuvants test
  • 4. Mouse Immune system of the mouse has been investigated more extensive than that of the Guinea pig Advantages – short duration and minimal animal treatment Example: 1. Mouse ear swelling test 2. Local lymph node assay
  • 5. Guinea pig maximisation test • The guinea pig maximisation test (GPMT) is an in vivo test to screen for substance that cause human skin sensitisation (i.e. Allergens) • It was first proposed by B. Magnussom and albert kligman in 1669 and described in their 1970 book contact dermatitis in the guinea pi
  • 6. General principle of sensitisation test • The test animal are initially exposed to the test substance by intra dermal injection and epidermal application • Following a rest period of 10 to 14 days during which an immune response developed, the animal are exposed to a challange dose • The degree of skin reaction to the challange exposure in test animal is compared with control group animals
  • 7. Element common to sensitisation test in Guinea Pig 01 Guinea pig Animal 03 250-500g Body weight 05 Temperature=20℃ HR=30-70% 12hrs light & 12hrs dark Housing 02 Male Female (non pregnant) Sex 04 At least 5 days prior to the test Acclimatization 06 Feeding
  • 8. Method NUMBER OF ANIMAL A minimum of 10 animal are used in the treatment group and at least 5 animals in the control group are used (20 test and 10 control) INDUCTION: INTRADERMAL INJECTION Day 0 – treated group 1. Three pair of intradermal injection are given in the shoulder region 1/1 mixture of FCA/water or saline 2. Test substance in an appropriate vehicle at the selected concentration 3. Test substance in a 1/1mixture of FCA/water or saline
  • 9. Day 0 – control group Control groupe also receive three intradermal injection, but only vehicle is used Day 5-7: Treated and control group 24 hrs before topical application, The test area after close clipping or saving painted with 0.5 ml of 10% sod lauryl sulphate In Vaseline, in order to creat a local irritation
  • 10. Day 6-8 : treated group Shaving Test substance applied to test area for 48 hrs Day 6-8 : control group Shaving Only vehicle are applied in similar manner for 48 hrs
  • 11. Day 20-22 : treated and control group A patches loaded with test substance is applied to flank of animal And A patches loaded with vehicle is applied to other side of flank For 24 hrs Observation : treated and control group Remove patch after 24 hrs Clean area after 21 hrs of patch removal Observe after 3 hrs (appropriate 48 hrs after challange) Approximately 24 hrs after this observation A second observation 72 hrs
  • 12. Scale for the evaluation of challenge patch test reaction 3=Intense erythema and swelling 2=Moderate erythema 1=Discrete or patchy erythema 0=No visible change
  • 13. Rechallenge • If it is necessary to clarify the results obtaine d in the first challenge • A second challenge 1. With a new control group / original group 2. Should be considered approximately one week after the first one 3. Rechallenge may also be performed on the original control group
  • 14. Clinical observation All skin reactions and any unusual findings, including systematic reactions, result from induction and challenge procedures should be observed and recorded
  • 15. Buehler test • The bhehler test is an in vivo test to screen for substance that cause human skin sensitisation (i.e. Allergens) • It was first proposed by Edwin Buehler in 1965 and further explained in 1980.
  • 16. Number of animals : • A minimum of 20 animals is used in the treatment group and at least 10 animals in the control group Dose levels : • The concentration for each induction exposure should be the highest to cause (mild irritation) • The concentration used for the challenge exposure should be the highe st (non-irritating dose) • The appropriate concentration can be determined from pilot study Using two or three animals
  • 17. Methode Induction : Topical application Day 0 – treated group One flank is cleared of hair (closely clipped) The test patch system should be fully loaded with test substance in a suitable vehicle is applied to the test area and held in contact with the skin for 6 hours. Day 0 - control group One flank is cleared of hair (closely clipped) The only vehicle applied on a similar manner of test application.
  • 18. Days 6 – 8 and 13 – 15 treated and control group The some application as on day 0 is carried out on the same test area of same flank on day 6-8 and again on day 13-15. Challenge Day 27 – 29 treated and control groups • The untreated flank of treated and control animals is cleared of hair. • An occlusive patch or chamber containing the appropriate amount of test substance is applied, at the maximum non irritant concentration, to the posterior untreated flank of treated and control animals • The patches or chambers are held in contact by a suitable dressing for 6 hours.
  • 19. Observation – treated and control groups : • Challenge area is cleared of hair 21 hours after removing the patch • 3 hours later the skin reaction are observed and recorded • Approximately 24 hours after the skin reaction observed and recorded Rechallenge: To clarify the results obtained in the first challenge
  • 20. Clinical observations • All skin reactions • Any usual findings 1. Systemic reactions • To clarify doubtful reactions 1. Histopathological examination 2. Measurement of skin fold thickness
  • 21. Reference OECD (1992) , Skin sensitisation. OECD Guideline for the testing of Chemicals No. 406, Paris, France.
  • 22. Thank you Insert the title of your subtitle Here